Dalriada Drug Discovery Collaborates With Antibe Therapeutics to Enable the Rapid Advancement

Dalriada’s Client Dunad Therapeutics just emerged out of Stealth mode, backed by Epidarex Capital

Our Client Janpix Ltd Presents Their Program Updates at the Virtual AACR and EHA Meetings

SilcsBio and Dalriada Launch Partnership to Create a Rapid Drug Discovery Service Suite

Dalriada Welcomes its Newest Client, Champignon Brands

Dalriada Remains Operational During COVID-19: Series of Safety Measures Implemented